Clinical trials
Infection, Hospital clinical trials
Below are recruiting infection, hospital clinical trials, each written for real people, not researchers. We’re tracking 417 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07089186RecruitingPhase 3
Study of meropenem and pralurbactam for certain antibiotic-resistant infections
This trial tests a combination of two antibiotics (meropenem and pralurbactam) for treating serious infections caused by bacteria that are resistant to many other antibiotics. It may be an option for hospitalized patients with pneumonia, urinary tract infections, abdominal infections, or bloodstream infections.
ShanghaiAges 18–80 - NCT06910878Recruiting
Studying resistant bacteria in urine infections
This study looks at urine infections caused by certain resistant bacteria. If you had a UTI treated by your family doctor between June and December 2024, your doctor may help us learn more about these infections and how to treat them better.
StrasbourgAges 18 years+ - NCT06286007Recruiting
How whooping cough and RSV affect asthma in adults
This study looks at how infections like whooping cough and RSV impact asthma symptoms and control in adults. It aims to understand if these infections make asthma worse, which could help improve future treatment and prevention.
Santiago de Compostela, A CoruñaAges 18–99 - NCT06578702Recruiting
Intermittent HIV triple therapy study in real life
This study looks at how well intermittent triple therapy works for people with HIV in real-world settings. It may help researchers understand if taking breaks from standard treatment is safe and effective.
StrasbourgAges 18 years+ - NCT07684300Recruiting
Testing a faster infection test to improve antibiotic use
This trial looks at whether a rapid molecular test can help doctors choose the right antibiotics faster for hospitalized patients. It aims to improve how antibiotics are used and reduce unnecessary side effects.
Elche, AlicanteAges 18 years+ - NCT06986980Recruiting
Gut Infection After Heart Transplant Study
This study looks at a rare gut infection (microsporidiosis) in people who have had a heart transplant. If you had this infection before 2025 and the diagnosis was made in France, your medical records may be reviewed to learn more about the infection.
Clermont-FerrandAges Any age - NCT07303114Recruiting
HIV screening missed in general practice study
This study looks at missed chances for HIV testing in general doctor offices. It focuses on people who were diagnosed with HIV between 2021 and 2024.
StrasbourgAges 18 years+ - NCT07335965Recruiting
Recurring Lyme disease after travel
This study looks at people who have had Lyme disease more than once after traveling abroad. It aims to understand the patterns of the infection and why it comes back.
StrasbourgAges 1 year+ - NCT07343089Recruiting
Study of Lyme disease during anti-CD20 treatment in France
This study looks at people who got a serious form of Lyme disease while being treated with a type of biologic drug called an anti-CD20 (such as rituximab). The goal is to learn more about these cases and improve care. You may join if you had Lyme disease confirmed by a DNA test within two years of taking this medicine.
StrasbourgAges 1 year+ - NCT07343167Recruiting
Study of factors linked to death in certain strep blood infections
This study looks at people who had a bloodstream infection caused by a specific group of streptococcus bacteria (Streptococcus anginosus group). The goal is to understand what factors might be linked to death in these infections.
StrasbourgAges 18 years+ - NCT05824988Recruiting
Testing antibiotic dose levels for MAC lung infection
This trial studies how much medicine is needed (based on lab results) to treat MAC lung disease, an infection in the lungs. If you already have MAC and are receiving the recommended core antibiotics, your care may help researchers link treatment details to lab measurements.
ShanghaiAges 18 years+ - NCT07240350Recruiting
Hepatitis B immune response in surgery patients
This study looks at how the body's immune system responds in people with chronic hepatitis B who also need surgery on certain organs. The goal is to learn more about the immune reaction in tonsils, lymph nodes, or other tissues to help find better treatments for hepatitis B.
Guangzhou, GuangdongAges 18–75 - NCT04961593Recruiting
Studying caspofungin dosing in very ill children
This study looks at how caspofungin works in children who are very sick and in the pediatric intensive care unit. It helps doctors better choose dosing to keep the medicine at the right level.
Shanghai, Shanghai MunicipalityAges 3 months–18 years - NCT06458231Recruiting
Measuring central line infection rates in sepsis patients
This study is about finding how common bloodstream infections are in people with central lines (a special IV for long-term medicines). It will help doctors learn how to prevent these infections.
Port SaidAges 1 day+ - NCT06703918Recruiting
C. Diff Infection Study in Babies
This study looks at Clostridium difficile (C. diff) infections in babies under 2. It compares babies who have the infection with those who don't, using medical records to learn more about how it affects them.
Hangzhou, Zhejiang, ChinaAges birth–2 years - NCT07030673Recruiting
Stopping antibiotics early in older adults with viral infections
This trial tests whether elderly patients hospitalized with a viral lower respiratory infection can safely stop antibiotics early. It aims to reduce unnecessary antibiotic use and side effects.
AmiensAges 65 years+ - NCT04535661Recruiting
Study of who develops carbapenem-resistant infections in PICU children
This study looks at factors that make some hospitalized children in the pediatric intensive care unit (PICU) develop or carry germs called carbapenem-resistant Enterobacteriaceae. It aims to understand who is at higher risk and why, which may help prevent infections in the future.
Shanghai, Shanghai MunicipalityAges 4 weeks–18 years - NCT05708508RecruitingPhase 3
Immune-guided vs universal medicine to prevent CMV after kidney transplant
This study compares two strategies to prevent a viral infection called CMV after kidney transplant. It tests whether an “immune-guided” approach (using your immune test results) can prevent CMV as well as or better than giving preventive antiviral medicine to everyone.
RouenAges 18–75 - NCT06331364Recruiting
Treating lung infections with better antibiotic decisions in Sri Lanka
This study tests whether a new way of deciding when to use antibiotics helps patients with lower respiratory infections (like pneumonia or bronchitis) in Sri Lankan hospitals. If you were recently admitted with a new lung infection, you may be able to join.
BalapitiyaAges 14 years+ - NCT06236022RecruitingPhase 4
Sirolimus for dilated cardiomyopathy with KSHV infection
This trial tests whether the drug sirolimus (rapamycin) can help people with dilated cardiomyopathy who also have a specific virus (KSHV) in their blood. It aims to see if sirolimus can improve heart function.
Wuhan, HubeiAges 18–70 - NCT07268560Recruiting
Testing a new antibiotic combination for certain drug-resistant infections
This trial is checking how well a combination of two antibiotics, aztreonam and avibactam, works in patients who have a specific type of drug-resistant bacterial infection in the belly or lungs. It aims to offer a new treatment option for infections that are hard to cure.
Nanchang, JiangxiAges 18 years+ - NCT03418441Recruiting
Study infections of the brain and spinal fluid in Denmark
This trial focuses on people in Denmark who may have an infection in the brain or the fluid around the brain and spinal cord. Researchers aim to collect and compare diagnostic results for different infection types (viral meningitis, bacterial meningitis, encephalitis, and others) to help confirm the cause and guide care.
AalborgAges 18 years+ - NCT06682533Recruiting
Comparing tegoprazan and PPI for H. pylori treatment
This trial compares two different types of stomach-acid-lowering medicines — tegoprazan and a proton pump inhibitor (PPI) — to see which works better at clearing H. pylori infection. It's for people who have not been treated for H. pylori before and can safely have a stomach scope.
SeoulAges 20–80 - NCT04653610Recruiting
Study immune signals in untreated HIV using extra samples
This study looks at tiny cell “messengers” in blood and stool to understand how HIV behaves before and after starting treatment. You may be eligible if you have untreated HIV (or you’re a healthy volunteer) and can commit to many sample visits, including long-term storage for 20 years.
Ghent, Oost-VlaanderenAges 18–65
Hear when a new Infection, Hospital trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for infection, hospital?
- Yes. Clin2 currently lists 417 recruiting infection, hospital studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a infection, hospital trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a infection, hospital trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.